Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure

Journal of the American Veterinary Medical Association

Volumn 226, Issue 3, 2005, Pages 393-400

  Jacob, Frédéric ^a   Polzin, David J ^a   Osborne, Carl A ^a   Neaton, James D ^b   Kirk, Claudia A ^c   Allen, Timothy A ^d   Swanson, Laurie L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

^d Hill's Pet Nutrition Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PROTEIN;

ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DOG DISEASE; KIDNEY FUNCTION; MORBIDITY; MORTALITY; NONHUMAN; PROTEIN URINE LEVEL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; UREMIA;

ANIMALS; CAUSE OF DEATH; COHORT STUDIES; CREATININE; DOG DISEASES; DOGS; FEMALE; KIDNEY FAILURE, CHRONIC; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEINURIA; RISK FACTORS; SURVIVAL ANALYSIS;

ANIMALIA; CANIS FAMILIARIS;

EID: 12744281104     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.226.393     Document Type: Article

References (31)

1. Burton C, Harris KPG. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996;27:765-775.
2. Remuzzi G. Nephropathic nature of proteinuria. Curr Opin Nephrol Hypertens 1999;8:655-663.
3. Walls J. Relationship between proteinuria and progressive renal disease. Am J Kidney Dis 2001;37(suppl 2):S13-S16.
4. Klahr S, Levey AS, Beck GJ, et al. The effect of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group. N Engl J Med 1994;330:877-884.
5. Praga M, Hernandez E, Montoyo C, et al. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1992;20:240-248.
6. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study. Ann Intern Med 1995;13:754-762.
7. Ruggenenti P, Perna A, Mosconi L, et al. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int Suppl 1997;52(suppl 63):S54-S57.
8. Ruggenenti P, Perna A, Gherardi G, et al. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril efficacy in nephropathy. Lancet 1998;352:1252-1256.
9. Ruggenenti P, Perna A, Mosconi L, et al. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857-1863.
10. Hostetter TH. Progression of renal disease. In: Greenberg A, ed. Primer on kidney diseases. 2nd ed. San Diego: Academic Press Inc, 1998;429-432.
11. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-2000.
12. Grauer GF, Greco DS, Getzy DM, et al. Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. J Vet Intern Med 2000;14:526-533.
13. Grodecki KM, Gains MJ, Baumal R, et al. Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. J Comp Pathol 1997;117:209-225.
14. Jacob F, Polzin DJ, Osborne CA, et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic renal failure in dogs. J Am Vet Med Assoc 2002;220:1163-1170.
15. Grauer GF, DiBartola SP. Glomerular disease. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine: diseases of the dog and cat. 5th ed. Philadelphia: WB Saunders Co, 2000;1662-1678.
16. Lott JA, Stephan VA, Pritchard KA Jr. Evaluation of Coomassie brilliant blue G-250 method for urinary protein. Clin Chem 1983;29:1946-1950.
17. Jacob F, Polzin DJ, Osborne CA, et al. Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure. J Am Vet Med Assoc 2003;222:322-329.
18. Glantz SA. How to test for trends. In: Glantz SA, ed. Primer of biostatistics. 4th ed. New York: McGraw-Hill Book Co, 1997;256-262.
19. Glantz SA. The special case of two groups: the t-test. In: Glantz SA, ed. Primer of biostatistics. 4th ed. New York: McGraw-Hill Book Co, 1997;65-103.
20. Glantz SA. How to analyze survival data. In: Glantz SA, ed. Primer of biostatistics. 4th ed. New York: McGraw-Hill Book Co, 1997;373-402.
21. Meier P. Anatomy and interpretation of Cox regression model. ASAIO J 1985;8:3-12.
22. Finco DR. Association of systemic hypertension with renal injury in dogs with induced renal failure. J Vet Intern Med 2004;18:289-294.
23. Meyer TW. Tubular injury in glomerular disease. Kidney Int 2003;63:774-787.
24. Mackenzie HS, Taal MW, Luyckx VA. Adaptation to nephron loss. In: Brenner BM, ed. The kidney. 6th ed. Philadelphia: WB Saunders Co, 2000;1901-1942.
25. D'Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int 2003;63:809-825.
26. Cook AK, Cowgill LD. Clinical and pathological features of protein-losing glomerular disease in the dog: a review of 137 cases (1985-1992). J Am Anim Hosp Assoc 1996;32:313-322.
27. Nath KA. The tubulointerstitium in progressive renal disease. Kidney Int 1998;54:992-994.
28. Remuzzi G. Renal protection: progression, regression, remission from nephropathy beyond blood pressure control. Int J Clin Pract 2000;110(suppl):9- 15.
29. Wenzel UO, Troschau G, Schoeppe W, et al. Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension. Hypertension 1992;20:233-241.
30. Brown SA, Walton CL, Crawford P, et al. Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria. Kidney Int 1993;43:1210-1218.
31. Kloke HJ, Branten AJ, Huysmans FT, et al. Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers? Kidney Int 1998;53:1559-1573.